Kv Pharmaceutical
As of the edition of 20 October 2026, Kv Pharmaceutical runs 6 drugs, 6 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 6 |
| Total | 6 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Estradiol | Ends 2032 (patent) | 6 |
| Clindamycin | none listed | 0 |
| Potassium chloride | none listed | 0 |
| Clindamycin phosphate | none listed | 0 |
| Hydroxyprogesterone caproate | none listed | 1 |
| Potassium | none listed | 0 |
A route B row is one company at one target.